Orphazyme
Series BOrphazyme raised €20M in a Series B round in Jan 2015. The company is based in Copenhagen, Denmark. Investors in the round: Aescap, IDInvest Partners, Sunstone Capital. Data as of 4 Nov 2026.
Amount raised
€20M
€19,767,729
Native amount
24,000,000 USD
Stage
Series B
series b
Investors
3
Provenance & confidence
UnverifiedAmount
24,000,000 USD
ECB-at-date → €20M · rate 1.2141 on 2014-12-31
High confidence
Source
No source on record — unverified.
Unverified
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
3 namedDate
Jan 2015
Round type
series b
Amount (EUR)
€20M